Literature DB >> 11948015

Expression of progesterone receptor isoforms A and B is differentially regulated by estrogen in different breast cancer cell lines.

Annika Vienonen1, Heimo Syvälä, Susanna Miettinen, Pentti Tuohimaa, Timo Ylikomi.   

Abstract

Progesterone action in target tissues is mediated through two progesterone receptor (PR) isoforms, PR-A and PR-B, which display different regulatory functions in target cells. Relative expression ratio of these isoforms varies depending on cell and tissue types. Here, we studied the regulation of PR isoform expression by estradiol (E(2)), insulin, IGF-1 and cAMP in different breast cancer cell lines. Although, E(2) induced PR expression in all cell lines studied, the expression ratio of PR-A/PR-B induced by E(2) was dependent on the cell line. The differential regulation of the isoforms was also seen at the mRNA level suggesting that the PR-A and PR-B promoters are differentially regulated by E(2) in different breast cancer cells. Insulin, IGF-1 or cAMP previously reported to induce PR expression however failed to alter the PR expression in our study. This is the first report describing that in different breast cancer cell lines the expression of PR-A and PR-B is regulated by E(2) in a distinct way.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11948015     DOI: 10.1016/s0960-0760(02)00027-4

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  9 in total

Review 1.  Progesterone receptors, their isoforms and progesterone regulated transcription.

Authors:  Britta M Jacobsen; Kathryn B Horwitz
Journal:  Mol Cell Endocrinol       Date:  2011-09-17       Impact factor: 4.102

2.  Rapid effect of GNRH1 on follicle-stimulating hormone beta gene expression in LbetaT2 mouse pituitary cells requires the progesterone receptor.

Authors:  Beum-Soo An; Song Ling Poon; Wai-Kin So; Geoffrey L Hammond; Peter C K Leung
Journal:  Biol Reprod       Date:  2009-04-08       Impact factor: 4.285

3.  Dual roles of progesterone in embryo implantation in mouse.

Authors:  Bojie Dai; Yujing Cao; Weimin Liu; Sumin Li; Yongjun Yang; Dayuan Chen; Enkui Duan
Journal:  Endocrine       Date:  2003-07       Impact factor: 3.633

Review 4.  Progesterone receptor isoform functions in normal breast development and breast cancer.

Authors:  Anastasia Kariagina; Mark D Aupperlee; Sandra Z Haslam
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2008       Impact factor: 1.807

5.  Antiprogestin mifepristone inhibits the growth of cancer cells of reproductive and non-reproductive origin regardless of progesterone receptor expression.

Authors:  Chelsea R Tieszen; Alicia A Goyeneche; BreeAnn N Brandhagen; Casey T Ortbahn; Carlos M Telleria
Journal:  BMC Cancer       Date:  2011-05-27       Impact factor: 4.430

6.  Phosphorylation of estrogen receptor alpha serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer.

Authors:  Hiroko Yamashita; Mariko Nishio; Shunzo Kobayashi; Yoshiaki Ando; Hiroshi Sugiura; Zhenhuan Zhang; Maho Hamaguchi; Keiko Mita; Yoshitaka Fujii; Hirotaka Iwase
Journal:  Breast Cancer Res       Date:  2005-07-27       Impact factor: 6.466

7.  Pyridoxine 5'-phosphate oxidase is correlated with human breast invasive ductal carcinoma development.

Authors:  Weimin Ren; Wencai Guan; Jinguo Zhang; Fanchen Wang; Guoxiong Xu
Journal:  Aging (Albany NY)       Date:  2019-04-14       Impact factor: 5.682

8.  Classification of PR-positive and PR-negative subtypes in ER-positive and HER2-negative breast cancers based on pathway scores.

Authors:  Taobo Hu; Yan Chen; Yiqiang Liu; Danhua Zhang; Jiankang Pan; Mengping Long
Journal:  BMC Med Res Methodol       Date:  2021-05-22       Impact factor: 4.615

9.  Association between Cyclooxygenase-2 and Indoleamine 2,3-Dioxygenase Expression in Breast Cancer Patients from Pakistan.

Authors:  Kashif Asghar; Asif Loya; Iftikhar Ali Rana; Muhammad Abu Bakar; Asim Farooq; Muhammad Tahseen; Muhammad Ishaq; Muhammad Usman Rashid
Journal:  Asian Pac J Cancer Prev       Date:  2019-11-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.